Counterpoint: The evidence does not support universal screening and treatment in children

Area of Science:

• Pediatric Cardiology
• Preventive Medicine
• Public Health Policy

Background:

• Pediatric lipid guidelines have become highly controversial.
• Current guidelines for childhood lipid screening and treatment are based on indirect evidence linking childhood risk factors to adult cardiovascular disease (CVD).
• Direct evidence establishing this link is currently unavailable.

Purpose of the Study:

• To synthesize arguments opposing universal lipid screening and treatment in children.
• To critically evaluate the evidence base for current pediatric lipid guidelines.

Main Methods:

• Review and synthesis of existing literature and arguments against universal pediatric lipid screening.
• Analysis of the strength of indirect evidence used to formulate current guidelines.
• Examination of potential harms and limitations associated with childhood lipid screening and treatment.

Main Results:

• Significant debate exists regarding the strength of indirect evidence linking childhood risk factors to adult CVD outcomes.
• Arguments against universal screening include historical precedents of unanticipated harms from interventions based on indirect evidence.
• Concerns are raised about the poor performance characteristics of lipid profiles as screening tools in children, issues with in-office testing effectiveness, and the safety of statin use in pediatric populations.

Conclusions:

• The foundation of universal pediatric lipid screening and treatment relies on indirect evidence, which is subject to considerable debate.
• Potential risks, including screening test inaccuracies and adverse effects of treatments like statins, warrant careful consideration.
• Further research is needed to establish direct links between childhood lipid profiles and adult CVD outcomes before widespread implementation of screening and treatment.